Sleep Therapy Devices
The U.S. sleep therapy device market is growing with rising sleep apnea prevalence, increasing diagnosis rates, and wider adoption of home-based and connected treatment technologies. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across CPAP systems, BiPAP devices, sleep monitors, masks, and diagnostic equipment.
The U.S. AI-enabled sleep therapy devices market is projected to grow from USD 3.82 billion in 2026 to USD 10.24 billion by 2032, advancing at a 17.85% CAGR. Expansion is propelled by high undiagnosed OSA prevalence, strict CMS adherence mandates, and the clinical transition toward closed-loop auto-titrating PAP, smart neurostimulation, and cloud-based predictive remote patient monitoring ecosystems.
Read Report Details
U.S. Digital Sleep Therapy Devices Market, connected CPAP devices, digital sleep apnea therapy US, smart mandibular advancement devices, home sleep apnea testing HSAT, sleep neurostimulation devices, remote patient monitoring sleep medicine, digital therapeutics for insomnia, sleep disorder breathing devices.
Read Report Details
The U.S. connected sleep therapy devices market is expanding from USD 4.19 billion in 2026 to USD 8.48 billion by 2032, exhibiting a 12.45% CAGR. Growth is propelled by high obstructive sleep apnea prevalence, Medicare compliance verification rules, and cellular-enabled APAP adoption that automates adherence tracking, DME remote resupply workflows, and clinical integration across domestic home healthcare networks.
Read Report Details
The U.S. portable sleep therapy devices market is expanding rapidly, projected to grow from USD 1.58 billion in 2026 to USD 2.94 billion by 2032 at a 10.85% CAGR. Momentum is propelled by rising obstructive sleep apnea prevalence, direct-to-consumer cash-pay purchasing, waterless humidification breakthroughs, and active travel lifestyles requiring ultra-light, auto-adjusting positive airway pressure and oral appliance alternatives.
Read Report Details
The U.S. home sleep therapy devices market is expanding rapidly, projected to grow from USD 6.12 billion in 2026 to USD 10.15 billion by 2032 at an 8.80% CAGR. Growth is driven by the massive undiagnosed obstructive sleep apnea population, expanding home sleep testing, auto-titrating positive airway pressure adoption, recurring mask and consumable resupply schedules, and cloud-connected adherence monitoring.
Read Report Details
The U.S. Non-Invasive Sleep Therapy Devices Market is projected to expand from USD 6.30 billion in 2026 to USD 10.74 billion by 2032 at a 9.30% CAGR. Growth is anchored by an undiagnosed pool of over 85 million adults, decentralized home sleep testing, CMS adherence mandates, and recurring DME replenishment of masks and consumables across major healthcare networks.
Read Report Details
The U.S. Positive Airway Pressure Devices Market is set to grow from USD 1.55 billion in 2026 to USD 2.45 billion by 2032, advancing at a 7.90% CAGR. Growth is anchored by vast undiagnosed obstructive sleep apnea cases, rising chronic respiratory co-morbidities, rapid transitions to cloud-connected home care, and high-margin recurring mask and consumable replacement programs.
Read Report Details
The U.S. Central Sleep Apnea Devices Market is set to expand from USD 1.24 billion in 2026 to USD 1.86 billion by 2032 at a 6.98% CAGR. Growth is accelerated by rising heart failure prevalence, opioid-induced respiratory depression, AI-driven diagnostic screening, and the clinical adoption of phrenic nerve neurostimulation and adaptive servo-ventilation systems across American healthcare networks.
Read Report Details
The U.S. Obstructive Sleep Apnea Devices Market is set to expand from USD 4.10 billion in 2026 to USD 6.69 billion by 2032, advancing at an 8.50% CAGR. Growth is propelled by over 39 million affected individuals, rapid migration toward convenient home sleep testing, rising CPAP adoption, and expanding coverage for oral appliances and hypoglossal nerve stimulation.
Read Report Details
The U.S. sleep apnea therapy devices market is projected to reach USD 11.24 billion by 2032 from USD 6.35 billion in 2026, expanding at a 10.00% CAGR. Growth is driven by expanding home diagnostic throughput, cloud-connected positive airway pressure ecosystems, recurring high-margin mask resupply cycles, and rapid procedural uptake of hypoglossal nerve stimulation implants across outpatient surgical centers.
Read Report Details